Mirvaso Side Effects

Generic Name: brimonidine topical

Note: This page contains information about the side effects of brimonidine topical. Some of the dosage forms included on this document may not apply to the brand name Mirvaso.

Not all side effects for Mirvaso may be reported. You should always consult a doctor or healthcare professional for medical advice. Side effects can be reported to the FDA here.

For the Consumer

Applies to brimonidine topical: topical application gel/jelly

In addition to its needed effects, some unwanted effects may be caused by brimonidine topical (the active ingredient contained in Mirvaso). In the event that any of these side effects do occur, they may require medical attention.

You should check with your doctor immediately if any of these side effects occur when taking brimonidine topical:

More common
  • Flushing or redness of the skin
  • unusually warm skin
Less common
  • Blemishes on the skin
  • blistering, burning, crusting, dryness, or flaking of the skin
  • itching, scaling, severe redness, soreness, or swelling of the skin
  • pimples

Some of the side effects that can occur with brimonidine topical may not need medical attention. As your body adjusts to the medicine during treatment these side effects may go away. Your health care professional may also be able to tell you about ways to reduce or prevent some of these side effects. If any of the following side effects continue, are bothersome or if you have any questions about them, check with your health care professional:

Less common
  • Blurred vision
  • burning, crawling, itching, numbness, prickling, "pins and needles", or tingling feelings
  • fever
  • headache
  • muscle aches
  • sore throat
  • stuffy or runny nose
  • unusual tiredness or weakness

For Healthcare Professionals

Applies to brimonidine topical: topical gel

General

The most commonly reported adverse reactions are erythema, pruritus, flushing and skin burning sensation.[Ref]

Dermatologic

Common (1% to 10%): Erythema, pruritus, skin burning sensation, rosacea, allergic contact dermatitis
Uncommon (0.1% to 1%): Dermatitis, skin irritation, warm skin, contact dermatitis, dry skin, pain of skin, skin discomfort, papular rash, acne[Ref]

Hypersensitivity

Common (1% to 10%): Allergic contact dermatitis[Ref]

Cardiovascular

Common (1% to 10%): Flushing[Ref]

Nervous system

Common (1% to 10%): Headache
Uncommon (0.1% to 1%): Paresthesia[Ref]

Ocular

Common (1% to 10%): Blurred vision, increased intraocular pressure
Uncommon (0.1% to 1%): Eyelid edema[Ref]

Respiratory

Common (1% to 10%): Nasopharyngitis
Uncommon (0.1% to 1%): Nasal congestion[Ref]

Gastrointestinal

Uncommon (0.1% to 1%): Dry mouth[Ref]

Other

Uncommon (0.1% to 1%): Feeling hot, peripheral coldness[Ref]

References

1. "Product Information. Mirvaso (brimonidine topical)." Galderma Laboratories Inc, Cranbury, NJ.

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. This information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate safety, effectiveness, or appropriateness for any given patient. Drugs.com does not assume any responsibility for any aspect of healthcare administered with the aid of materials provided. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the substances you are taking, check with your doctor, nurse, or pharmacist.

Hide
(web4)